Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
Xuexiang Han(Center for Excellence in Molecular Cell Science), Michael J. Mitchell(California Institute for Regenerative Medicine), Yi Zhong(Peking University), Lulu Xue(University of Pennsylvania), Ningqiang Gong(University of Science and Technology of China), James J. Knox(University of Pennsylvania), Guangjun Nie(National Center for Nanoscience and Technology), Paul Bates(University of Pennsylvania), Majed Ghattas(Polytechnique Montréal), Drew Weissman(California University of Pennsylvania), Mohamad‐Gabriel Alameh(Children's Hospital of Philadelphia), Kendall A. Lundgreen(University of Pennsylvania), Ying Xu(Nankai University), Marc Lavertu(Polytechnique Montréal), Junchao Xu(University of Pennsylvania), Kamila Butowska(University of Gdańsk)
Cited by 227
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940